Autism stem cell therapy is an emerging area of research and clinical application. Although it is too early to promise anything solid, the preclinical and clinical evidence reveal the safety and tolerance of the therapy. Besides, the evidence showed a significant reduction in neuroinflammation, improvement in cellular communication and cellular regeneration. Mesenchymal stem cells (MSCs) showed immunomodulatory, anti-inflammatory and regenerative properties. Currently, there is a need to launch a large-scale clinical trial for establishing long-term safety and success of the therapy. For detailed information reach us out at Advancells, India
Â
For detailed knowledge contact- Advancells
Contact us: +91-9654321400
Visit us : https://www.advancells.com/
mail : info@advancells.com
Â
Â